Evaluation of in vivo DNA damaging and oxidative stress effects of sertraline
dc.contributor.author | Aktas, Ayca | |
dc.contributor.author | Battal, Dilek | |
dc.contributor.author | Sungur, Mehmet Ali | |
dc.contributor.author | Yalin, Serap | |
dc.contributor.author | Kadioglu, Ela | |
dc.contributor.author | Eker, Ebru Derici | |
dc.contributor.author | Saygi, Sahan | |
dc.contributor.author | Aktaş, Ayça | |
dc.contributor.author | Battal, Dilek | |
dc.contributor.author | Sungur, Mehmet Ali | |
dc.contributor.author | Yalın, Serap | |
dc.contributor.author | Kadıoğlu, Ela | |
dc.contributor.author | Eker, Ebru Derici | |
dc.contributor.author | Saygı, Şahan | |
dc.date.accessioned | 2020-05-01T12:16:40Z | |
dc.date.available | 2020-05-01T12:16:40Z | |
dc.date.issued | 2013 | |
dc.department | DÜ, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü | en_US |
dc.description | 49th Congress of the European-Societies-of-Toxicology (EUROTOX) -- SEP 01-04, 2013 -- Interlaken, SWITZERLAND | en_US |
dc.description | WOS: 000323865800391 | en_US |
dc.description.abstract | Sertraline, SSRI group of medicine, is the most frequently prescribed drug and well-known fact that central nervous system medication. In this study, the potential influence of the therapies with the different doses of sertraline on DNA damaging, lipid peroxidation levels and antioxidant enzyme activities were investigated. For this purpose Male Wistar Albino rats were divided into four group: control (n = 6), low (10 mg/kg/day), moderate (40 mg/kg/day), and high dose (80 mg/kg/day). Each treatment group had 6 animals and sertraline were administered by gavage throughout 28 days of the study. The alkaline comet assay and the cytokinesis-block micronucleus (CBMN) assay were used to evaluate DNA damaging potential of sertraline in the peripheral blood lymphocytes (PBLs). There is no statistically significant difference between sertraline treated groups and the negative control group with respect to comet assay results (p > .05). According to the data obtained from the CBMN test, an increase in the micronucleus (MN) frequency was detected only at high dose sertraline treatment. Serum paroxanase (PON), catalase (CAT), and superoxyde dismutase (SOD) activities were determined as well as malondialdehyde (MDA) lipid peroxidation for evaluation of oxidative stress effects of sertraline treatment. Serum SOD activities showed increase, CAT and PON activities decreased in all groups. Lipid peroxidation levels (MDA) increased in all sertraline treated rats (p < 0.05). Based on the data, it can be concluded that high dose sertraline administration enhances oxidative stress. Therefore, dose adjustment in depression patients seems significant as it may help prevention of further prognosis of the diseases. | en_US |
dc.description.sponsorship | European Soc Toxicol (EUROTOX), ECETOC, Roche, Syngenta, AstraZeneca, Sanofi, Basilea Pharmaceutica, ACEA Biosciences Inc, European Crop Protect, Bioservice Sci Labs GmbH, Oekotoxzentrum Ctr Ecotox, Swiss Confederat, Fed Dept Home Affairs, Fed Off Publ Hlth (FOPH), BASF, SCAHT, Johnson & Johnson, Janssen Pharmaceut Co, Natl Ctr Replacement, Refinement & Reduct Anim Res, ILSI, SERVIER, RCC, Nestle, Suva Pro, Interpharma, Covance, Novartis, Merck, BioReliance | en_US |
dc.identifier.doi | 10.1016/j.toxlet.2013.05.236 | en_US |
dc.identifier.endpage | S128 | en_US |
dc.identifier.issn | 0378-4274 | |
dc.identifier.startpage | S128 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.toxlet.2013.05.236 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12684/6407 | |
dc.identifier.volume | 221 | en_US |
dc.identifier.wos | WOS:000323865800391 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Ireland Ltd | en_US |
dc.relation.ispartof | Toxicology Letters | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Evaluation of in vivo DNA damaging and oxidative stress effects of sertraline | en_US |
dc.type | Conference Object | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Küçük Resim Yok
- İsim:
- 6407.pdf
- Boyut:
- 79.87 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text